For best results, ABREVA should be applied earlier in the cold sore cycle, at the tingle/bump/tightness/redness stage. This is why it's best to keep an extra tube of ABREVA ever-handy.
No. ABREVA is not indicated for preventive therapy.
Healing time varies from person to person. In clinical trials, ABREVA was shown to reduce healing time to a median of 4.1 days versus 4.8 days with placebo.*
It is estimated that a tube of ABREVA should last the average cold sore sufferer at least one full episode when used as directed (applied 5 times a day).
No. It is important to use ABREVA as directed on the package.
ABREVA is indicated for adults and children 12 years and older. ABREVA has not been tested on pregnant or breastfeeding women. These patients should consult a physician before using ABREVA.
ABREVA contains a moisturizing ingredient in its cream base, however some people may have abnormally dry lips, and using a moisturizer may be of benefit to treat severe chapping.
* Sacks SL et al. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: a multicenter, randomized, placebo-controlled trial. J Am Acad Dermatol 2001: 45:222-230
*ABREVA Risk-Free Guarantee: If you aren't completely satisfied for any reason, save your receipt and remaining product, and call 1-877-709-3539 to get your money back.